Doyle Frank, De La Harpe Davida, McGee Hannah, Shelley Emer, Conroy Ronán
Department of Epidemiology and Public Health Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Eur J Cardiovasc Prev Rehabil. 2005 Aug;12(4):376-9. doi: 10.1097/01.hjr.0000160725.82293.63.
Gender differences in presentation and management of acute coronary syndromes (ACS) are well established internationally. This study investigated differences in a national Irish sample.
Cross-sectional survey.
All centres (n=39) admitting cardiac patients to intensive/coronary care provided information on 25 consecutive acute myocardial infarction patients and other ACS patients admitted concurrently (n=1365 episodes). Patient data was analyzed in terms of those with prior ACS/revascularization, and those without.
Men with prior established ACS/revascularization were twice as likely to have received revascularization procedures (coronary artery bypass graft or percutaneous coronary intervention) prior to admission when controlling for age, total cholesterol and insurance status [odds ratio (OR) 1.97, 95% confidence interval (CI) 1.18-3.29, P=0.011]. No gender differences were seen in acute-phase reperfusion (OR 0.96, 95% CI 0.76-1.24, P>0.05) or antiplatelet therapy (OR 0.99, 95% CI 0.69-1.41, P>0.05). For patients with prior ACS/revascularization, men were twice as likely to receive statins on discharge after adjustment for age and total cholesterol (OR 1.94, 95% CI 1.02-3.71, P=0.045).
Women were treated differently to men. Fewer women with a positive history of ACS received revascularization prior to current admission and fewer women were prescribed lipid-lowering medications on discharge. Acute phase hospital treatment was not gender determined. These findings have implications for secondary prevention in Ireland.
急性冠状动脉综合征(ACS)在临床表现和治疗方面的性别差异在国际上已得到充分证实。本研究调查了爱尔兰全国样本中的差异。
横断面调查。
所有收治心脏病患者至重症监护室/冠心病监护病房的中心(n = 39)提供了25例连续急性心肌梗死患者以及同期收治的其他ACS患者(n = 1365例次)的信息。患者数据根据既往有ACS/血运重建史和无此病史进行分析。
在控制年龄、总胆固醇和保险状况后,既往有确诊ACS/血运重建史的男性在入院前接受血运重建手术(冠状动脉搭桥术或经皮冠状动脉介入治疗)的可能性是女性的两倍[比值比(OR)1.97,95%置信区间(CI)1.18 - 3.29,P = 0.011]。在急性期再灌注(OR 0.96,95% CI 0.76 - 1.24,P>0.05)或抗血小板治疗(OR 0.99,95% CI 0.69 - 1.41,P>0.05)方面未观察到性别差异。对于既往有ACS/血运重建史的患者,在调整年龄和总胆固醇后,男性出院时接受他汀类药物治疗的可能性是女性的两倍(OR 1.94,95% CI 1.02 - 3.71,P = 0.045)。
女性与男性的治疗方式不同。既往有ACS阳性病史的女性在本次入院前接受血运重建的较少,出院时开具降脂药物的女性也较少。急性期住院治疗并非由性别决定。这些发现对爱尔兰的二级预防具有启示意义。